SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-019053
Filing Date
2017-07-26
Accepted
2017-07-26 17:00:19
Documents
1
Period of Report
2017-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4491
  Complete submission text file 0000899243-17-019053.txt   6836
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101
Business Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101 206-441-5064
Alpine ImmunoSciences, L.P. (Reporting) CIK: 0001628571 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 17983556

Mailing Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101
Business Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101 206-441-5064
Alpine Bioventures GP, LLC (Reporting) CIK: 0001712676 (see all company filings)

State of Incorp.: WA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 17983555